Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy?

FierceBiotechRyghtAI launches clinical site search engine to aid drug developers, CROs with trial design

BioWorldSex differences shape gene activity across the human brain

FierceBiotechRare Disease Research, myTomorrows team up to help patients access trials

FierceBiotechAligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal

FierceBiotechPfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial

FierceBiotechJohnson & Johnson hands back failed eye disease gene therapy to MeiraGTx

FierceBiotech'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again

BioWorldFDA grants priority review to Merck-Daiichi’s B7-H3 cancer ADC

BioWorldMeta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

Thermo FisherThermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

PLoS BiologyGlucose is dynamically regulated by time of day in humans and <i>Drosophila</i>